Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
nucleotide |
| gptkbp:actsOn |
gptkb:AMP-activated_protein_kinase
|
| gptkbp:bannedIn |
gptkb:World_Anti-Doping_Agency
|
| gptkbp:CASNumber |
3031-94-5
|
| gptkbp:chemicalFormula |
C9H15N4O8P
|
| gptkbp:discoveredBy |
1950s
|
| https://www.w3.org/2000/01/rdf-schema#label |
AICAR
|
| gptkbp:IUPACName |
gptkb:5-Aminoimidazole-4-carboxamide_ribonucleotide
|
| gptkbp:metabolism |
intermediate in purine biosynthesis
|
| gptkbp:molecularWeight |
338.21 g/mol
|
| gptkbp:otherName |
gptkb:5-Aminoimidazole-4-carboxamide_ribonucleoside
gptkb:Acadesine |
| gptkbp:solubility |
gptkb:water
|
| gptkbp:studiedBy |
potential treatment of ischemic injury
potential treatment of metabolic disorders potential use in athletic performance enhancement |
| gptkbp:used_in |
biochemical research
|
| gptkbp:usedFor |
AMPK activator
|
| gptkbp:bfsParent |
gptkb:AMPK_pathway
gptkb:AMPK |
| gptkbp:bfsLayer |
6
|